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Introduction
Ghrelin is the first natural hormone to be identified in
which the serine residue in position 3 was estrified
with n-octanoic acid. Various functions were attributed
to this peptide, including the role in the release of
growth hormone (GH) from the pituitary gland and the
control of the energeting homeostasis that regulates the
energy usage by influencing the appetite – the pituitary
intestine axis [1-3]. This function is mediated by the
activation of the growth hormone secretagogue recep-
tor (GHS-R) type 1a [4,5]. Ghrelin is produced pre-
dominantly by the stomach and the lower amount by
other organs such as central nervous system (CNS) and
peripheral tissue [1,3,6]. But several authors have
questioned whether ghrelin expression really takes
place in the central nervous system. Katakami et al.,
using real-time polymerase chain reaction, show unde-
tectable levels in the cerebral cortex, or hypothalamus
of the rhesus monkey [7]. Thus it cannot be ruled out
that ghrelin in the hypothalamus may possibly derive
from peripheri. However, Korbonits et al. detected
ghrelin m-RNA message in the human and rat pituitary
and hypothalamus using reverse transcriptase poly-
merase chain reaction [6,8]. In adult patients with iso-
lated GH deficiency, ghrelin serum levels are similar
to those of the control subject and do not decrease after
one year of GH replacement therapy [9]. The presence
of ghrelin was shown also in numerous peripheral
organs during the intrauterine ontogenesis, however,
the role ghrelin plays in the period of intrauterine life
is not fully appreciated [10-12].
The aim of our study was to evaluate ghrelin
expression and of its receptor (GHS-R1a) in soma-
totrops and in neurones of brain tissue of the III and IV
ventricle in the process of fetal ontogenesis and evalu-
ation of the probable role of these proteins in this peri-
od of life. It was checked whether there was a correla-
tion between the degree of expression of ghrelin and
GHS-R in somatotrops and CNS. In this study the
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authors also looked for relations between GHRH
(Growth Hormone Releasing Hormone) and SS
(Somatostatine) in the pituitary and CNS neurones of
the studied fetuses.
Materials and methods
Eight pituitaries and eight brains from different periods of
intrauterine life were investigated. Organs for investigation were
taken during autopsy after about 8 hours after death. The deceased
newborns were kept in a refrigerator. Characterisation of the fetus-
es is presented in Table 1. The whole material was fixed in neu-
tralised formalin; the pituitaries were fixed for 3-5 days, the brains
for 2 weeks. Sections were taken from the area of the III and IV
ventricle, were fixed again and then paraffin emboded. The pitu-
itaries and brain material were cut serially, every 7th section was
stained with hematoxyline and eosin. Such a procedure allowed to
choose proper tissue sections for immunohistochemical studies. Of
the eight pituitaries studied in two, apart from the nervous and
glandular part, the presence of infundibular stalk and of the tuber-
alis part was found. In five pituitaries the nervous and glandular
parts were found while only in one pituitary the glandular part was
found. In the nervous tissue five fragments came from the area of
the III ventricle and in this case clusters of neurones localised in
the vicinity of the bottom. In the other three fragments dispersed
neurones were more often found, which were arranged in rows or
"in indian file". The data on the antibodies used for the study are
listed in Table 2.
Apart from antibodies used and listed in Table 2 in 1-5, there
were also used a rabbit antibody against ghrelin and a mouse anti-
body against GH in order to perform double staining on the same
section of the pituitary allowing to demonstrate both GH and ghre-
lin in somatotrops. As control material were used tissue sections
from an adenoma of human pituitary positive for ghrelin and GH.
Also a negative control was performed which consisted in omitting
the first antibody. As a positive control of ghrelin and the receptor
served sections of the pancreas from the 25th week of pregnancy
[10].
Results
A positive immunoreaction to the presence of ghrelin
was found in the glandular portion and in brain tissue.
Pituitary: in the glandular part already of the
youngest fetus from the 16th week of pregnancy an
immunopositive reaction was observed in dispersed or
concentrated cells in small clusters. Staining in the
area of the cell was localised in the cytoplasm, nuclei
were not stained. The number of immunopositive cells
increased as the pregnancy advanced until the 30th-35th
week. They were distributed in the peripheral glandu-
lar part of the pituitary, were concentrated nests and
were found in the area of the 3/4 of the glandular struc-
tures. In the remaining 1/4 of this part no positive reac-
tion was observed (10). In the period between the 35th
and 37th week of pregnancy the picture of distribution
of ghrelin-positive cells did not show any significant
differences as compared to the 30th-35th week of preg-
nancy. The degree of ghrelin expression was high and
similar during the whole period of intrauterine life of
the fetuses studied. In the nerves pituitary part the cells
were not stained.
Brain tissue: in the youngest fetuses single ghrelin-
positive cells occurred. As the age of fetuses advanced
the number of positive neurones was increasing in the
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Table 1. The list of studied fetuses according to the week of preg-
nancy, body mass, length of life
Table 2. The list of antibodies used, manufacturers, dilution and the techniques
area of the III ventricle, but the intensity of staining
was moderate and significantly weaker when com-
pared with somatotrops.
GHS-R1a
Localisation a receptor in the glandular part of the pitu-
itary and in brain tissue was similar to that of ghrelin.
Expression of immunoreaction in the glandular part of
the pituitary was similar to that of ghrelin whereas in the
neurones of brain tissue it was definitely stronger as
compared to the immunoreaction to ghrelin. Localisa-
tion of the immunopositive reaction to the presence of
GHS-R1a concerned cell membrane and cytoplasm.
Growth hormone
Positive immunoreaction to GH was observed only in
the glandular part of the pituitary. Already in the pitu-
itaries of the youngest fetuses (16th-18th week)
immunopositive somatotrops were collected in large
clusters. Staining reaction was localised in the cyto-
plasm and the nuclei were negative. In older fetuses of
up to 33rd-35th week of pregnancy the number of
growth hormone-rich cells was increasing. They were
located mainly in the peripheral part of the pituitary.
The degree of immunoreaction expression was inten-
sive throughout the whole intrauterine life of fetuses.
In the negative field of the glandular portion in the
staining for ghrelin and GHS-R no presence of GH
was shown either.
In the double staining reaction identifying soma-
totrops synthesising both ghrelin and GH were stained
cherry-russet (Fig. 1a). A similar picture was obtained
on the tissue sections, coming from the adenoma of a
human pituitary (Fig. 1b). In the somatotrops of the
fetal pituitary the immunoreaction demonstrating these
two hormones was more homogeneous while in the
adenoma it was stronger.
Neurohormones
Pituitary: of the 8 investigated pituitaries only in two a
infundibular stalk and tuberalis were found. They
came from the 32nd and 35th weeks of the intrauterine
life. In the stalk a positive immunoreaction was
observed to the presence of GHRH and SS in the form
of a fibrous delicate network forming delicate grains
on a fibrous background (Fig. 2). In the nervous and
tuberalis part and in the glandular part positive reac-
tion to both studied hormones was not observed.
Brain tissue: reaction to GHRH and somatostatin in
the material from the area of the III and IV ventricle
was observed in single neurones and in nests localised
in the area of the forming cerebral cortex (Fig. 3).
Within the III ventricle neurones were observed which
were arranged "in indian file". As the intrauterine age
was growing the number of positive neurones was
increasing up to the 32nd-36th weeks of pregnancy. A
positive reaction was observed in the neuroplasm and
in the appendages cell. The degree of expression was
different.
Discussion
The endogenic ghrelin induces GH secretion in the
pituitary somatotrops in man and in adult animals
[3,12,13]. Thus, it exerts a similar influence on soma-
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Fig. 1. A two-colour reaction mark-
ing somatotrops synthesising both
GH and ghrelin – cherry-russet
staining. (A) The pituitary of a
fetus from the 33rd week of
intrauterine life. Somatotrops
showing both hormones are
marked with arrows. (B) Adenoma
of human pituitary. The cherry-rus-
set staining marks cells which syn-
thesise both the studied hormones.
Hematoxylin counterstain (original
magnification ×300).
totrops as a whole group of non-peptide and peptide
growth hormone secretagogues – GHS which have
been discovered during the recent three decades
[3,14,15]. The intravenously administered ghrelin
induces during 15-20 minutes a maximal GH concen-
tration in blood serum, and administered continually
apart from GH secretion also induces growth of
appetite, fat accumulation, increase in acid secretion
and greater mobility of the stomach [1,6,16,17]. So
ghrelin, apart from the somatotropin system also takes
part in the brain-intestine axis [14]. The participation
of ghrelin in the brain-intestine axis may also be traced
in the intrauterine life of the fetuses. According to
some researchers glucose deficiency connected with
malnutrition of pregnant women, increases ghrelin
concentration in the serum of umbilical blood of new-
borns. It was shown in clinical observations and in an
experiment performed on laboratory animals [18,19].
In this field ghrelin acts with leptin forming a comple-
mentary regulating system which informs CNS about
the energetic condition of the organism. The mecha-
nism of ghrelin influence on somatotrops takes place
508 A. Kedzia et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(3): 508 (505-510) 
10.2478/v10042-009-0106-z
Fig. 2. (A) Positive reaction to
GHRH in the form of a delicate
brown net in the pedicle of a fetus
coming from the 33-weeks old
pregnancy. (B) Negative control.
Hematoxylin counterstain (original
magnification ×300).
Fig. 3. Positive reaction to the pres-
ence of GHRH and SS in the neu-
rones of the III ventricle surround-
ing of the brain. In the inset can be
seen a reaction to GHRH in the
cytoplasm and appendages of a sin-
gle neuronal cell. In the other neu-
rones can be seen a positive
immunoreaction to somatostatin.
Hematoxylin counterstain (original
magnification ×400 and ×300).
by the mediation of a receptor (GHS-R) which belongs
to a family of seven transepithelial receptor of the G
protein. This receptor is found mostly in the pituitary,
nuclei of the hypothalamus and, to a lesser degree in
the peripheral tissues [8]. The mechanism of ghrelin
activity in GH release from the pituitary has not been
fully recognised. Kineman and Luque studied the
mechanism of ghrelin and GHRH influence on GH
release in the culture of somatotrops of an adult
baboon [13]. There studies showed that the intracellu-
lar signal pathway of both these hormones are differ-
ent and increase GH secretion depending on the recep-
tor regulation. Mice deprived of the GHS-R gene lose
weight, ghrelin does not release GH secretion in the
pituitary and their organism is not capable of main-
taining an appropriate glucose level during starvation
and caloric restriction [20]. Rindi et al. emphasise, on
the basis of a survey of literature on the subject, that
the function of ghrelin in adults is not regulated by GH
through the classic feedback mechanism while studies
of ghrelin in the pituitary of human fetuses are excep-
tionally scarce and this problem was dealt with only
when ghrelin expression in the endocrine tumors of the
pituitary was evaluated [6,8,11,12]. In our study we
showed an immunopositive reaction to ghrelin in
somatotrops and in neurones concentrated mainly in
the area of the III ventricle of the brain already in the
youngest fetuses of 16th-18th weeks. Ghrelin expres-
sion was also accompanied by high GH activity in
somatotrops. GH presence in the somatotrops of the
human pituitary was shown as early as the 7th-10th
week of fetal life [12,21]. We showed that the signifi-
cantly higher ghrelin expression in somatotrops com-
pared with its presence in neurones may suggest a
great involvement of this hormone in the control of
GH synthesis in somatotrops. Whereas ghrelin expres-
sion in neurones was very moderate and its role in the
stimulation of GH secretion in somatotrops is unclear
and so far has not been fully explained. Of interest is
our observation pointing to a relatively high GHS-R
expression in neuronal cells with a slight ghrelin
expression. This phenomenon is difficult to explain at
present. It can only be suggested that the activity of
ghrelin receptor may be independent on the GHRH
receptor. According to some researchers the hypothal-
amus in human fetuses is differentiated into separate
nuclei as early as in the 12th week of intrauterine life
[22]. The concentrations of neurones which we have
observed may be the proof of a longer phase of forma-
tion of the hypothalamus nuclei and this fact may be
confirmed by the groups of neurones migrating ''one
after another" to their destinations. In the neurones
described we have found an immunopositive reaction
to somatostatin and GHRH. In the stalk of two pitu-
itaries from the 32nd-35th weeks of pregnancy we
showed an immunopositive reaction both to somato-
statin and GHRH. In the pituitary of younger fetuses
we have not observed these neurohormones [11]. Bres-
son et al. did not discover the presence of GHRH in the
brain until the 18th week of pregnancy while Aubert et
al. showed that there was somatostatin in the cortex
and hypothalamus already from the 11th week of preg-
nancy and expression of this hormone was increasing
until the 22nd week of pregnancy [23,24]. Furuhashi et
al. determined GH and SS concentration in the serum
of umbilical blood in newborns and their mothers, and
showed a more than four times higher GH concentra-
tion in the blood serum of fetuses than in their mothers
while the SS concentration was similar in mothers and
fetuses [25]. In the blood serum of mothers in the third
trimester of pregnancy GH comes mainly from the pla-
centa and so far there has been no proof of its trans-
mission to fetal circulation [26]. On the other hand, it
is assumed that GH in fetal circulation comes chiefly
from the fetal pituitary. It is curious that the concen-
tration of the placental GH in the blood serum of the
mother is correlated with the weight of the fetus while
ghrelin concentration in the serum of umbilical blood
of fetuses is not correlated with body mass index
(BMI), time of pregnancy, length of the fetus, and cir-
cumference of the head [27]. Our knowledge of the
fetal ghrelin is still limited, particularly when mecha-
nisms controlling GH production in fetal life are con-
cerned. Most authors emphasise that in fetal life GH
release by ghrelin from the pituitary is independent of
somatostatin corticostatin [12,14]. Our studies confirm
this suggestion. As the age of a fetus advanced the
number of neurones which synthesise both neurohor-
mones was increasing, this may suggest that also their
concentration in blood serum of the fetuses was grow-
ing in proportion to age.
To sum up, we can suggest that the stimulation of
GH secretion by ghrelin is independent of the feedback
concentration and these two hormones act as signals of
metabolic balance. GH release by ghrelin in fetal life
is independent of somatostatin. The hypothalamic-
pituitary axis which regulates the pulsatile GH release
from the pituitary matures functionally probably in the
third trimester of pregnancy independent of the previ-
ous anatomical differentiation.
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